Lynn Stockwell, Chairman of Drugs Made In America Acquisition II DMII, has filed 3 purchases and 4 sales on the open market. The latest trade was on 25/09/26.

LS

LS

Lynn Stockwell

CEO and Exe. Chair of Board

Company

Drugs Made In America Acquisition II DMII

First filing

23/06/01

Trades

20 trades

Buys / sales

3 / 4

12-month net buying

No record

Last trade

25/09/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Drugs Made In America Acquisition IIDMII	Open-market buy	25/09/26	25/10/01	700,000 sh	In footnote	No stated value	+4.9%
Drugs Made In America Acquisition IIDMII	Open-market sale	25/09/26	25/10/01	7,966,667 sh	In footnote	No stated value	−54.3%
Drugs Made In America AcquisitionDMAA	Open-market buy	25/02/18	25/02/18	30,000 sh	In footnote	No stated value	+0.7%
Drugs Made In America AcquisitionDMAA	Open-market buy	25/01/29	25/02/04	400,000 sh	In footnote	No stated value	No record
Drugs Made In America AcquisitionDMAA	Open-market sale	25/01/29	25/02/04	5,698,363 sh	In footnote	No stated value	−57.8%
BG Bright Green	Open-market sale	24/06/05	24/06/10	1,000,000 sh	$0.36	$360,000	−1.4%
BG Bright Green	Open-market sale	23/08/31	23/09/06	250,000 sh	$0.47	$117,500	−0.4%